Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Immune recovery uveitis.

G N Holland1

  • 1Department of Ophthalmology, UCLA Ocular Inflammatory Disease Center, UCLA School of Medicine, Jules Stein Eye Institute, Los Angeles, CA 90095-7003, USA.

Ocular Immunology and Inflammation
|December 28, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Combination of KIR and HLA gene variants augments the risk of developing birdshot chorioretinopathy in HLA-A*29-positive individuals.

Genes and immunity·2008
Same author

The AJO: electronic augmentation on the Internet.

American journal of ophthalmology·2002
Same author

Relationships between laser flare photometry values and complications of uveitis.

Archives of ophthalmology (Chicago, Ill. : 1960)·2001
Same author

The tubulointerstitial nephritis and uveitis syndrome.

Survey of ophthalmology·2001
Same author

Cluster of Mycobacterium chelonae keratitis cases following laser in-situ keratomileusis.

American journal of ophthalmology·2001
Same author

Decreased macular leukocyte velocity in human immunodeficiency virus-infected individuals.

American journal of ophthalmology·2001
Same journal

Role of Adjunctive Intravitreal Therapy in Intraocular Tubercular Granuloma at a Tertiary Uveitis Care Centre - A Retrospective Case Series.

Ocular immunology and inflammation·2026
Same journal

Sex Differences in Uveitis Etiology: A Systematic Review and Meta-Analysis.

Ocular immunology and inflammation·2026
Same journal

Upadacitinib in Refractory Vogt-Koyanagi-Harada Disease: A Case Report.

Ocular immunology and inflammation·2026
Same journal

Choroidal and Retinal Imaging Findings in Childhood-Onset Mevalonate Kinase Deficiency: An OCT-Based Case-Control Study.

Ocular immunology and inflammation·2026
Same journal

Efficacy of infliximab therapy in the treatment of idiopathic retinal vasculitis, aneurysms, and neuroretinitis (IRVAN) syndrome.

Ocular immunology and inflammation·2026
Same journal

Conjunctival Reactive Lymphoid Hyperplasia with Delayed Corneal Immune Infiltrates in the Setting of Systemic Epstein-Barr Virus Infection.

Ocular immunology and inflammation·2026
See all related articles

Antiretroviral therapy improves immune function in AIDS patients, but can trigger immune recovery uveitis. This ocular inflammation, linked to cytomegalovirus (CMV), causes vision loss and requires further study for effective long-term treatment.

Area of Science:

  • Ophthalmology
  • Immunology
  • Infectious Diseases

Background:

  • Potent antiretroviral therapy (ART) significantly improves immune function in patients with Acquired Immunodeficiency Syndrome (AIDS).
  • In patients with pre-existing cytomegalovirus (CMV) retinitis, improved immunity can paradoxically lead to increased intraocular inflammation, known as immune recovery uveitis (IRU).
  • IRU presents as anterior segment and vitreous inflammation, potentially causing chronic, vision-limiting complications like macular edema and epiretinal membrane formation.

Purpose of the Study:

  • To investigate the frequency and risk factors associated with immune recovery uveitis (IRU) in patients with AIDS and CMV retinitis.
  • To explore the underlying disease mechanisms of IRU, particularly the role of CMV antigens in ocular tissues.
  • To evaluate current treatment strategies for IRU and identify the need for effective long-term management.

Related Experiment Videos

Main Methods:

  • Observational study design to assess the occurrence of IRU.
  • Analysis of patient data to identify potential risk factors for IRU development.
  • Review of existing literature and clinical evidence regarding IRU pathogenesis and treatment.

Main Results:

  • Immune recovery uveitis (IRU) is a significant complication of ART in AIDS patients with CMV retinitis.
  • IRU is characterized by intraocular inflammation, leading to macular edema and vision loss.
  • Current treatment with corticosteroids offers transient relief, but long-term strategies remain unestablished.

Conclusions:

  • Immune recovery uveitis (IRU) is a common cause of new vision loss in AIDS patients with CMV retinitis.
  • Further research is needed to clarify the specific disease mechanisms and identify effective long-term treatments for IRU.
  • Understanding and managing IRU is crucial for preserving vision in immunocompromised patients undergoing effective antiretroviral therapy.